Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse

Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse

Bibliographic Details
Main Authors:	Lu, Q, Yokota, T, Bou-Gharios, G, Partridge, T, Fletcher, S, Wilton, S, Mann, C, Lou, F, Morris, G, Xue, SA
Format:	Conference item
Published:	2004

Similar Items

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
by: Lu, Q, et al.
Published: (2003)

Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery.
by: Aoki, Y, et al.
Published: (2012)

In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
by: Aoki, Y, et al.
Published: (2010)

Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.
by: Yokota, T, et al.
Published: (2012)

T-cell-dependent fibrosis in the mdx dystrophic mouse.
by: Morrison, J, et al.
Published: (2000)

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.
by: Goyenvalle, A, et al.
Published: (2010)

Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles.
by: Lu, Q, et al.
Published: (2005)

A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
by: Yin, H, et al.
Published: (2009)

Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration.
by: Yokota, T, et al.
Published: (2006)

Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse.
by: Morrison, J, et al.
Published: (2005)

Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
by: Betts, C, et al.
Published: (2018)

Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
by: Goyenvalle, A, et al.
Published: (2010)

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice.
by: Yin, H, et al.
Published: (2011)

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice
by: Yin, H, et al.
Published: (2011)

Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction.
by: Alexakis, C, et al.
Published: (2007)

Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle.
by: Ivanova, G, et al.
Published: (2008)

Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient
by: Saito, T, et al.
Published: (2010)

AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy
by: Le Hir, M, et al.
Published: (2013)

Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse.
by: Yin, H, et al.
Published: (2010)

Exon skipping peptide-pmos for correction of dystrophin in mouse models of duchenne muscular dystrophy
by: Betts, C, et al.
Published: (2014)

Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy
by: Blain, A, et al.
Published: (2018)

New Approach for Antisense Oligonucleotide-Mediated Exon Skipping in Duchenne Muscular Dystrophy.
by: Aoki, Y, et al.
Published: (2012)

Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties
by: Chwalenia, K, et al.
Published: (2022)

Heregulin ameliorates the dystrophic phenotype in mdx mice.
by: Krag, T, et al.
Published: (2004)

Exon skipping is correlated with exon circularization
by: Kelly, S, et al.
Published: (2015)

Context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency
by: Yin, HF, et al.
Published: (2016)

Increased susceptibility of the dystrophic mdx mouse heart to ischemic and hypoxic injuries
by: Zhang, W, et al.
Published: (2005)

Up-regulation of utrophin alleviates the dystrophic phenotype in the mdx mouse heart
by: Sang, E, et al.
Published: (2000)

Fetal microchimeric cells in a fetus-treats-its-mother paradigm do not contribute to dystrophin production in serially parous mdx females.
by: Seppanen, E, et al.
Published: (2012)

Challenges for antisense oligonucleotide-based therapeutics, in particular for exon 51-skipping in Duchenne muscular dystrophy
by: Aoki, Y, et al.
Published: (2011)

Upgrading U7snRNA To Complete Efficient Rescue of Dystrophin by Exon-Skipping in DMD Patients
by: Goyenvalle, A, et al.
Published: (2009)

Effect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscle
by: Eghtesad, Saman, et al.
Published: (2014)

Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan.
by: Rezniczek, G, et al.
Published: (2007)

In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy.
by: Wang, Q, et al.
Published: (2010)

Generation of clusters of dystrophin revertant fibers requires muscle regeneration and tests the function of dystrophin/utrophin transgenes
by: Yokota, T, et al.
Published: (2004)

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
by: Wakefield, P, et al.
Published: (2000)

RNA-seq analysis of an antisense sequence optimized for exon skipping in Duchenne patients reveals no off-target effect
by: Domenger, C, et al.
Published: (2017)

Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study.
by: Zhang, W, et al.
Published: (2008)

Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
by: Rafael, J, et al.
Published: (2000)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
by: Goyenvalle, A, et al.
Published: (2012)